38481807|t|Interruption of p38MAPK-MSK1-CREB-MITF-M pathway to prevent hyperpigmentation in the skin.
38481807|a|Background: Melanocortin 1 receptor (MC1R), a receptor of alpha-melanocyte-stimulating hormone (alpha-MSH), is exclusively present in melanocytes where alpha-MSH/MC1R stimulate melanin pigmentation through microphthalmia-associated transcription factor M (MITF-M). Toll-like receptor 4 (TLR4), a receptor of endotoxin lipopolysaccharide (LPS), is distributed in immune and other cell types including melanocytes where LPS/TLR4 activate transcriptional activity of nuclear factor (NF)-kappaB to express cytokines in innate immunity. LPS/TLR4 also up-regulate MITF-M-target melanogenic genes in melanocytes. Here, we propose a molecular target of antimelanogenic activity through elucidating inhibitory mechanism on alpha-MSH-induced melanogenic programs by benzimidazole-2-butanol (BI2B), an inhibitor of LPS/TLR4-activated transcriptional activity of NF-kappaB. Methods: Ultraviolet B (UV-B)-irradiated skins of HRM-2 hairless mice and alpha-MSH-activated melanocyte cultures were employed to examine melanogenic programs. Results: Topical treatment with BI2B ameliorated UV-B-irradiated skin hyperpigmentation in mice. BI2B suppressed the protein or mRNA levels of melanogenic markers, such as tyrosinase (TYR), MITF-M and proopiomelanocortin (POMC), in UV-B-exposed and pigmented skin tissues. Moreover, BI2B inhibited melanin pigmentation in UV-B-irradiated co-cultures of keratinocyte and melanocyte cells and that in alpha-MSH-activated melanocyte cultures. Mechanistically, BI2B inhibited the activation of cAMP response element-binding protein (CREB) in alpha-MSH-induced melanogenic programs and suppressed the expression of MITF-M at the promoter level. As a molecular target, BI2B primarily inhibited mitogen-activated protein kinase (MAPK) kinase 3 (MKK3)-catalyzed kinase activity on p38MAPK. Subsequently, BI2B interrupted downstream pathway of p38MAPK-mitogen and stress-activated protein kinase-1 (MSK1)-CREB-MITF-M, and suppressed MITF-M-target melanogenic genes, encoding enzymes TYR, TYR-related protein-1 (TRP-1) and dopachrome tautomerase (DCT) in melanin biosynthesis, and encoding proteins PMEL17 and Rab27A in the transfer of pigmented melanosomes to the overlaying keratinocytes in the skin. Conclusion: Targeting the MKK3-p38MAPK-MSK1-CREB-MITF-M pathway was suggested as a rationale to inhibit UV-B- or alpha-MSH-induced facultative melanogenesis and as a strategy to prevent acquired pigmentary disorders in the skin.
38481807	16	23	p38MAPK	Gene	26416
38481807	24	28	MSK1	Gene	73086
38481807	29	33	CREB	Gene	12912
38481807	60	77	hyperpigmentation	Disease	MESH:D017495
38481807	103	126	Melanocortin 1 receptor	Gene	17199
38481807	128	132	MC1R	Gene	17199
38481807	149	185	alpha-melanocyte-stimulating hormone	Gene	18976
38481807	187	196	alpha-MSH	Gene	70527
38481807	243	252	alpha-MSH	Gene	70527
38481807	253	257	MC1R	Gene	17199
38481807	268	275	melanin	Chemical	MESH:D008543
38481807	356	376	Toll-like receptor 4	Gene	21898
38481807	378	382	TLR4	Gene	21898
38481807	409	427	lipopolysaccharide	Chemical	MESH:D008070
38481807	429	432	LPS	Chemical	MESH:D008070
38481807	509	512	LPS	Chemical	MESH:D008070
38481807	513	517	TLR4	Gene	21898
38481807	623	626	LPS	Chemical	MESH:D008070
38481807	627	631	TLR4	Gene	21898
38481807	805	814	alpha-MSH	Gene	70527
38481807	847	870	benzimidazole-2-butanol	Chemical	-
38481807	872	876	BI2B	Chemical	-
38481807	895	898	LPS	Chemical	MESH:D008070
38481807	899	903	TLR4	Gene	21898
38481807	942	952	NF-kappaB.	Gene	18033
38481807	962	975	Ultraviolet B	Chemical	-
38481807	977	981	UV-B	Chemical	-
38481807	1003	1006	HRM	CellLine	
38481807	1018	1022	mice	Species	10090
38481807	1027	1036	alpha-MSH	Gene	70527
38481807	1146	1150	BI2B	Chemical	-
38481807	1163	1167	UV-B	Chemical	-
38481807	1179	1201	skin hyperpigmentation	Disease	MESH:D017495
38481807	1205	1209	mice	Species	10090
38481807	1211	1215	BI2B	Chemical	-
38481807	1286	1296	tyrosinase	Gene	22173
38481807	1298	1301	TYR	Gene	22173
38481807	1315	1334	proopiomelanocortin	Gene	18976
38481807	1336	1340	POMC	Gene	18976
38481807	1346	1350	UV-B	Chemical	-
38481807	1397	1401	BI2B	Chemical	-
38481807	1412	1419	melanin	Chemical	MESH:D008543
38481807	1436	1440	UV-B	Chemical	-
38481807	1513	1522	alpha-MSH	Gene	70527
38481807	1571	1575	BI2B	Chemical	-
38481807	1604	1641	cAMP response element-binding protein	Gene	12912
38481807	1643	1647	CREB	Gene	12912
38481807	1652	1661	alpha-MSH	Gene	70527
38481807	1777	1781	BI2B	Chemical	-
38481807	1852	1856	MKK3	Gene	26397
38481807	1887	1894	p38MAPK	Gene	26416
38481807	1910	1914	BI2B	Chemical	-
38481807	1949	1956	p38MAPK	Gene	26416
38481807	2004	2008	MSK1	Gene	73086
38481807	2010	2014	CREB	Gene	12912
38481807	2088	2091	TYR	Gene	22173
38481807	2093	2114	TYR-related protein-1	Gene	22063
38481807	2116	2121	TRP-1	Gene	22063
38481807	2127	2149	dopachrome tautomerase	Gene	13190
38481807	2151	2154	DCT	Gene	13190
38481807	2159	2166	melanin	Chemical	MESH:D008543
38481807	2203	2209	PMEL17	Gene	20431
38481807	2214	2220	Rab27A	Gene	11891
38481807	2333	2337	MKK3	Gene	26397
38481807	2338	2345	p38MAPK	Gene	26416
38481807	2346	2350	MSK1	Gene	73086
38481807	2351	2355	CREB	Gene	12912
38481807	2411	2415	UV-B	Chemical	-
38481807	2420	2429	alpha-MSH	Gene	70527
38481807	2502	2522	pigmentary disorders	Disease	MESH:C535508
38481807	Association	MESH:C535508	20431
38481807	Association	MESH:D017495	12912
38481807	Association	MESH:C535508	11891
38481807	Positive_Correlation	18033	21898
38481807	Association	12912	70527
38481807	Association	11891	20431
38481807	Bind	MESH:D008070	21898
38481807	Association	MESH:D017495	26416
38481807	Association	MESH:D017495	73086
38481807	Association	26416	73086
38481807	Association	MESH:D008543	70527
38481807	Association	12912	73086
38481807	Positive_Correlation	MESH:D008070	18033
38481807	Association	26397	26416
38481807	Association	MESH:D008543	17199
38481807	Bind	17199	70527
38481807	Association	12912	26416

